41
Participants
Start Date
January 28, 2019
Primary Completion Date
February 16, 2023
Study Completion Date
September 30, 2026
Aldesleukin
"PROLEUKIN® 18 x 106 IU~Powder for solution for injection or infusion"
Placebo
sterile diluent used for the aldesleukin preparation and 5% glucose
Oxford Children's Hospital, Oxford
Bristol Royal Hospital for Children, Bristol
Addenbrooke's Hospital, Cambridge
The Great North Children's Hospital, Newcastle upon Tyne
Nottingham Children's Hospital, Nottingham
Collaborators (1)
Oxford Clinical Trials Research Unit (OCTRU)
UNKNOWN
Centre for Statistics in Medicine, Oxford
UNKNOWN
Juvenile Diabetes Research Foundation
OTHER
Wellcome Trust
OTHER
University of Oxford
OTHER